SIGLEC15 Antibody | CSB-PA064103

(No reviews yet) Write a Review
SKU:
CSB-PA064103
Availability:
3 to 7 Working Days
  • SIGLEC15 Antibody
  • The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using CSB-PA064103 (SIGLEC15 Antibody) at dilution 1/35, on the right is treated with synthetic peptide. (Original magnification: ×200)
  • The image on the left is immunohistochemistry of paraffin-embedded Human lung cancer tissue using CSB-PA064103 (SIGLEC15 Antibody) at dilution 1/35, on the right is treated with synthetic peptide. (Original magnification: ×200)
£252.64 - £390.96

Description

SIGLEC15 Antibody | CSB-PA064103 | Cusabio

SIGLEC15 Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: SIGLEC15

Aliases: sialic acid binding Ig-like lectin 15

Background: Siglec-15 (sialic acid binding Ig-like lectin 15), also known as CD33L3, is a 328 amino acid single-pass type I membrane protein that contains one Ig-like C2-type domain and one Ig-like V-type domain. Expressed in dendritic and macrophage cells, Sinlec-15 interacts with DAP10 and DAP12 and binds to sialylated glycoproteins. The gene encoding Siglec-15 maps to human chromosome 18, which houses over 300 protein-coding genes and contains nearly 76 million bases.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: Q6ZMC9

Host Species: Rabbit

Species Reactivity: Human

Immunogen: Synthetic peptide of human SIGLEC15

Immunogen Species: Human

Applications: ELISA, IHC

Tested Applications: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

Purification Method: Antigen affinity purification

Dilution Ratio1: ELISA:1:1000-1:2000

Dilution Ratio2: IHC:1:25-1:100

Dilution Ratio3:

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Others

Research Areas: Others

View AllClose

0 Reviews

View AllClose